Extended premix and vitamin collaboration
Danish Agro, Vestjyllands Andel and Agravis extend their strategic collaboration.
Danish Agro and Vestjyllands Andel are extending their strategic collaboration with German agribusiness group Agravis Raiffeisen AG within premix and vitamins.
Danish Agro and Vestjylland's joint venture company, Vilomix International Holding A/S, has just acquired 25% of the shares in German premix and vitamin company Hamburger Leistungsfutter Gmbh from Agravis. Agravis previously owned 80% of the shares in the company. Hamburger Leistungsfutter Gmbh is a German premix and vitamin company based in Hamburg with annual turnover of DKK 1 billion, and activities in over 40 different countries.
Agravis Raiffeisen has also increased its shareholding in the Vilomix group from 15% to 25%. The Vilomix group, based in Lime and also specialising in premix and vitamins, has an annual turnover of DKK 2.3 billion and interests in over 25 countries.
According to Danish Agro's Group CEO, Christian Junker, the acquisitions are a natural extension of the fruitful strategic collaboration enjoyed by the partners to date.
- Agravis is a close strategic partner with whom we have developed a large number of successful international activities. Our investments in Vilomix and Hamburger Leistungsfutter are a natural extension of this partnership, and we see a lot of synergy between the two companies. Vilomix and Hamburger Leistungsfutter are both well-established international companies, able to supplement each other really well on a number of export markets, stated Junker.
Peter Iversen, CEO of the Vilomix group, expects a lot of potential from closer collaboration with his German colleagues.
- Vilomix and Hamburger Leistungfutter focus strongly on specialist expertise and quality products, and I look forward to strengthening these areas for both companies via increased dialogue and exchange of know-how. Both companies are also extremely active internationally, where we also expect to benefit from each other, says Peter Iversen.
The transactions are awaiting final approval from the competition authorities.